Novocure Announces Positive Topline Results from Phase 2 PANOVA-4 Clinical Trial of Tumor Treating Fields Therapy for Metastatic Pancreatic Cancer
Novocure Announces Optune Lua® Receives Reimbursement Approval in Japan for the Treatment of Non-Small Cell Lung Cancer
Tumor Treating Fields Therapy to be Covered for Patients with Newly Diagnosed Glioblastoma Through British Columbia Cancer
Novocure Announces Preliminary Full Year and Fourth Quarter 2025 Performance and Provides Company Update
Novocure to Present New Research for Tumor Treating Fields Therapy at European Association of Neuro-Oncology Meeting and the European Society for Medical Oncology Congress
Quebec Innovative Materials:Advancing Canadian and American Natural Hydrogen for the Next Energy Cycle
